Zobrazeno 1 - 10
of 47
pro vyhledávání: '"Dylan P Thibault"'
Autor:
Heather K Hayanga, Kaitlin E Woods, Dylan P Thibault, Matthew B Ellison, Roosevelt N Boh, Bryan D Raybuck, Partho P Sengupta, Vinay Badhwar, J W Awori Hayanga
Publikováno v:
Annals of Cardiac Anaesthesia, Vol 26, Iss 1, Pp 29-35 (2023)
Background: General anesthesia has traditionally been used in transcatheter aortic valve replacement; however, there has been increasing interest and momentum in alternative anesthetic techniques. Aims: To perform a descriptive study of anesthetic ma
Externí odkaz:
https://doaj.org/article/3b88f6f24c314cce90e1f4fb3c99b348
Autor:
James A G Crispo, Allison W Willis, Dylan P Thibault, Yannick Fortin, Harlen D Hays, Douglas S McNair, Lise M Bjerre, Dafna E Kohen, Santiago Perez-Lloret, Donald R Mattison, Daniel Krewski
Publikováno v:
PLoS ONE, Vol 11, Iss 3, p e0150621 (2016)
Elderly adults should avoid medications with anticholinergic effects since they may increase the risk of adverse events, including falls, delirium, and cognitive impairment. However, data on anticholinergic burden are limited in subpopulations, such
Externí odkaz:
https://doaj.org/article/387d9a62b1124eef935a0f5f29a2423f
Publikováno v:
BMC Neurology, Vol 18, Iss 1, Pp 1-10 (2018)
Abstract Background There is limited data on the effects of medication-related adverse events occurring during inpatient stays for stroke. The objectives of our study were to characterize reasons for acute readmission after acute ischemic stroke (AIS
Externí odkaz:
https://doaj.org/article/4cf361c98a804a63852436d329d12467
Publikováno v:
J Neurosci Nurs
BACKGROUND: Persons with Parkinson disease (PD) have complex care needs that may benefit from enhanced nursing care provided in Magnet-designated hospitals. Our primary objective was to determine whether an association exists between hospital Magnet
Publikováno v:
Neurol Clin Pract
ObjectiveTo determine the effect of International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) to International Classification of Diseases, 10th Revision, Clinical Modification (ICD-10-CM) coding transition on the poin
Publikováno v:
Journal of Parkinson's Disease
Background: Advances in the treatment of Parkinson’s disease (PD) have allowed for improvements in mortality and quality survival, making the management of comorbid conditions of aging, such as osteoarthritis, crucial. Objective: To determine the e
Autor:
Oliver K. Jawitz, Andrew M. Vekstein, Rebecca Young, Sreekanth Vemulapalli, Brittany A. Zwischenberger, Dylan P. Thibault, Sean O’Brien, David M. Shahian, Vinay Badhwar, Vinod H. Thourani, Jeffrey P. Jacobs, Peter K. Smith
Publikováno v:
The Annals of thoracic surgery.
Public interest in stratifying hospital performance has led to the proliferation of commercial, consumer-oriented hospital rankings. In cardiac surgery, little is known about how these rankings correlate with clinical registry quality ratings.The Soc
Autor:
Dylan P. Thibault, Dominique R. Ansell, Britney Le, Melanie Squarzolo, James Crispo, Connie Marras, Danielle Ouellette, Salimah Z. Shariff, Allison W. Willis, Dallas Seitz, Melody Lam
Publikováno v:
Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 48:372-382
Objectives:To compare long-term survival of Parkinson’s disease (PD) patients with deep brain stimulation (DBS) to matched controls, and examine whether DBS was associated with differences in injurious falls, long-term care, and home care.Methods:U
Autor:
Dylan P. Thibault, Shavonne L. Massey, Jennifer Glusman, Christina L. Szperka, Allison W. Willis, Nicholas S. Abend, Sudha Kilaru Kessler, Leah J. Blank, James A.G. Crispo
Publikováno v:
Pediatric Neurology. 108:93-98
Background The burden and characteristics of unplanned readmission after epilepsy-related discharge in children in the United States is not known. Methods We undertook a retrospective cohort study of children aged one to 17 years discharged after a n
Publikováno v:
Neurol Clin Pract
ObjectiveReadmission is used as a quality indicator and is the primary target outcome for disease-modifying therapy (DMT) for multiple sclerosis (MS). However, data on readmissions for patients with MS are limited.MethodsUsing the US Nationwide Readm